Metabolic syndrome distribution based on diagnostic criteria and family history among adults in Al-Basra, Iraq
Accepted: 14 July 2023
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Background. Metabolic syndrome (MetS) is a collection of cardiovascular risk factors induced by insulin resistance and an inflammatory state that increases the likelihood of developing type 2 diabetes and a variety of cardiovascular disorders. Objective. The study aims to determine the distribution of MetS by diagnostic criteria and family history among adults in Al- Basra province, southern Iraq. Methods. A cross-sectional study was conducted at the Al- Fiaha Specialized Diabetes, Endocrine, and Metabolism Center (FDEMC) from October 2nd, 2022, to May 1st, 2023. Following ethical approval, data was obtained using a pre-tested questionnaire. All patient information was obtained from direct interviews as well as FDEMC’s digital records, which controlled patient data via a Microsoft Access program and an internal network. Results. This study included 476 people, aged 19 to 89. The sample had an equal number of males and females (238). MetS was identified in 247 people in the entire sample using the International Diabetes Federation criteria. The proportion of participants with a family history was as follows: obesity (30.0%), hypertension (44.1%), diabetes mellitus (46.6%), and cardiovascular disease (9.3%). The diagnostic criteria for MetS were as follows: high wc (94.3%), elevated glucose (69.6%), reduced highdensity lipoprotein (HDL) (80.2%), elevated TG (40.5%), and hypertension (71.7%). Controlled on glycemic status (21.1%), hypertension (61.9%), and lipids (44.1%). Conclusion. Large wc, reduced HDL, and family histories of obesity, hypertension, diabetes mellitus, or cardiovascular disease are the most important risk factors for MetS. Participants with MetS have difficulties controlling their blood sugar, but they regulate the other MetS components.
Kelishadi R, Hovsepian S, Djalalinia S, Jamshidi F, Qorbani M. A systematic review on the prevalence of metabolic syndrome in Iranian children and adolescents. J Res Med Sci Off J Isfahan Univ Med Sci. 2016;21. DOI: https://doi.org/10.4103/1735-1995.192506
Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008;28(4):629–36. DOI: https://doi.org/10.1161/ATVBAHA.107.151092
Aguilar-Salinas CA, Viveros-Ruiz T. Recent advances in managing/understanding the metabolic syndrome. F1000Research. 2019;8. DOI: https://doi.org/10.12688/f1000research.17122.1
O’Neill S, O’Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16(1):1–12. DOI: https://doi.org/10.1111/obr.12229
Dagpo TD, Nolan CJ, Delghingaro-Augusto V. Exploring therapeutic targets to reverse or prevent the transition from metabolically healthy to unhealthy obesity. Cells. 2020;9(7):1596. DOI: https://doi.org/10.3390/cells9071596
Woo KS, Hu YJ, Chook P, Wei AN, Chan R, Yin YH, et al. A Tale of Three Gorges in the Yangtze River: Comparing the Prevalence of Metabolic syndrome According to ATPIII, WHO, and IDF Criteria and the Association with Vascular Health in Modernizing China. Metab Syndr Relat Disord. 2019;17(3):137–42. DOI: https://doi.org/10.1089/met.2018.0091
Flemming GMC, Bussler S, Körner A, Kiess W. Definition and early diagnosis of metabolic syndrome in children. J Pediatr Endocrinol Metab. 2020;33(7):821–33. DOI: https://doi.org/10.1515/jpem-2019-0552
Reisinger C, Nkeh-Chungag BN, Fredriksen PM, Goswami N. The prevalence of pediatric metabolic syndrome—A critical look on the discrepancies between definitions and its clinical importance. Int J Obes. 2021;45(1):12–24. DOI: https://doi.org/10.1038/s41366-020-00713-1
Saleh AA, Hayawi AH, Al-Samarrai AY, Lafta RK. Metabolic syndrome among obese adults in Baghdad, Iraq. Saudi J Obes. 2017;5(1):8.
Pérez-Martínez P, Mikhailidis DP, Athyros VG, Bullo M, Couture P, Covas MI, et al. Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation. Nutr Rev. 2017;75(5):307–26. DOI: https://doi.org/10.1093/nutrit/nux014
Owolabi EO, Ter Goon D, Adeniyi OV, Adedokun AO, Seekoe E. Prevalence and correlates of metabolic syndrome among adults attending healthcare facilities in Eastern Cape, South Africa. Open Public Health J. 2017;10(1). DOI: https://doi.org/10.2174/1874944501710010148
Ali Mansour A. METABOLIC SYNDROME AMONG ADULTS POPULATION SINGLE CENTER EXPERANCE IN BASRAH. Med J Basrah Univ. 2005;23(1):38–41. DOI: https://doi.org/10.33762/mjbu.2005.47319
Okafor CI. The metabolic syndrome in Africa: current trends. Indian J Endocrinol Metab. 2012;16(1):56. DOI: https://doi.org/10.4103/2230-8210.91191
Unger T, Borghi C, Charchar F, Khan NA, Poulter NR, Prabhakaran D, et al. 2020 International Society of Hypertension global hypertension practice guidelines. Hypertension. 2020;75(6):1334–57. DOI: https://doi.org/10.1161/HYPERTENSIONAHA.120.15026
Zhang J-S, Gui Z-H, Zou Z-Y, Yang B-Y, Ma J, Jing J, et al. Long-term exposure to ambient air pollution and metabolic syndrome in children and adolescents: a national cross-sectional study in China. Environ Int. 2021;148:106383. DOI: https://doi.org/10.1016/j.envint.2021.106383
Xiao J, Wu C-L, Gao Y-X, Wang S-L, Wang L, Lu Q-Y, et al. Prevalence of metabolic syndrome and its risk factors among rural adults in Nantong, China. Sci Rep. 2016;6(1):38089. DOI: https://doi.org/10.1038/srep38089
Kiama CN, Wamicwe JN, Oyugi EO, Obonyo MO, Mungai JG, Roka ZG, et al. Prevalence and factors associated with metabolic syndrome in an urban population of adults living with HIV in Nairobi, Kenya. Pan Afr Med J. 2018;29(1):1–9. DOI: https://doi.org/10.11604/pamj.2018.29.90.13328
Ranasinghe P, Cooray DN, Jayawardena R, Katulanda P. The influence of family history of hypertension on disease prevalence and associated metabolic risk factors among Sri Lankan adults. BMC Public Health. 2015;15:1–9. DOI: https://doi.org/10.1186/s12889-015-1927-7
Hu X, Yu W, Yang L, Pan W, ya Si Q, Chen X, et al. The association between first-degree family history of diabetes and metabolic syndrome. Endocr Pract. 2019;25(7):678–83. DOI: https://doi.org/10.4158/EP-2018-0543
Engin A. The definition and prevalence of obesity and metabolic syndrome. Obes lipotoxicity. 2017;1–17. DOI: https://doi.org/10.1007/978-3-319-48382-5_1
Niwa K. Metabolic syndrome in adult congenital heart disease. Korean Circ J. 2019;49(8):691–708. DOI: https://doi.org/10.4070/kcj.2019.0187
Greenfield DM, Snowden JA. Cardiovascular diseases and metabolic syndrome. EBMT Handb Hematop Stem Cell Transplant Cell Ther. 2019;415–20. DOI: https://doi.org/10.1007/978-3-030-02278-5_55
Lee S, Ko Y, Kwak C, Yim E. Gender differences in metabolic syndrome components among the Korean 66-year-old population with metabolic syndrome. BMC Geriatr. 2016;16:1–8. DOI: https://doi.org/10.1186/s12877-016-0202-9
Farmanfarma K, Ansari-Moghaddam A, Kaykhaei M, Mohammadi M, Adineh H, Aliabd H. Incidence of and factors associated with metabolic syndrome, south-east Islamic Republic of Iran. East Mediterr Heal J. 2021;27(11):1084–91. DOI: https://doi.org/10.26719/emhj.21.051
Venugopal V, Dongre AR, Saravanan S. Prevalence and determinants of metabolic syndrome among the rural adult population of Puducherry. Indian J Community Med Off Publ Indian Assoc Prev Soc Med. 2019;44(1):21.
Ji M, Ren D, Dunbar-Jacob J, Gary-Webb TL, Erlen JA. Self-management behaviors, glycemic control, and metabolic syndrome in type 2 diabetes. Nurs Res. 2020;69(2):E9–17. DOI: https://doi.org/10.1097/NNR.0000000000000401
Tune JD, Goodwill AG, Sassoon DJ, Mather KJ. Cardiovascular consequences of metabolic syndrome. Transl Res. 2017;183:57–70. DOI: https://doi.org/10.1016/j.trsl.2017.01.001
Grundy SM. Metabolic syndrome update. Trends Cardiovasc Med. 2016;26(4):364–73. DOI: https://doi.org/10.1016/j.tcm.2015.10.004
Roshan H, Nikpayam O, Sedaghat M, Sohrab G. Effects of green coffee extract supplementation on anthropometric indices, glycaemic control, blood pressure, lipid profile, insulin resistance and appetite in patients with the metabolic syndrome: a randomised clinical trial. Br J Nutr. 2018;119(3):250–8. DOI: https://doi.org/10.1017/S0007114517003439
Paredes S, Fonseca L, Ribeiro L, Ramos H, Oliveira JC, Palma I. Novel and traditional lipid profiles in metabolic syndrome reveal a high atherogenicity. Sci Rep. 2019;9(1):1–7. DOI: https://doi.org/10.1038/s41598-019-48120-5
Copyright (c) 2023 the Authors
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.